StockTipsArenaBeta

BUY Wockhardt Limited — Sachin Janardan Sarvade, IDBI Capital Markets and Securities

BUYWockhardt Limited
Wockhardt share price target & all analyst calls

bySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesHorizon: NA (inferred Swing (≤2wk))9 Nov 2026via NDTV Profit (Live)

Entry₹1,992.1Inferred
Target₹2,480
Total upside +24.49%
Stop loss₹1,769-11.20% risk
CMP₹2,027.21d ago
Active+1.76%+22.34%upside left 8d left
Follow Sachin Janardan Sarvade for new calls(15% target hit, 94 closed calls)Get alertsWatch WOCKPHARMA for new buy/sell callsGet alertsSee 281 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:31 am IST
4 supporting1 opposing
Supports the BUY call (4)

MACD above its signal line — bullish momentum

Technicals · macd·14 Nov · today

Wockhardt reported Q2 FY27 revenue of Rs 969 crore, up 24% year-on-year, with EBITDA of Rs 165 crore and PAT of Rs 73 crore. The company also provided updates on its antibiotic pipeline and biotech gr

BSE · Company Update·2 Nov · 2w ago

(opens in new tab)

Wockhardt reported Q2 FY27 revenue of Rs 969 crore, up 24% year-on-year, and PAT of Rs 73 crore. The company highlighted strong growth in biotech operations and progress in its novel antibiotic portfo

NSE · Press Release·2 Nov · 2w ago

(opens in new tab)

Wockhardt Ltd reported standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, showing growth in revenue and profitability compared to the previous year.

BSE · Board Meeting·2 Nov · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

RSI at 73 — overbought territory

Technicals · rsi·14 Nov · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Wockhardt

All analyst calls on Wockhardt

More from Sachin Janardan Sarvade, IDBI Capital Markets and Securities

Every call and its outcome